Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT

    The optimal conditioning for patients with higher risk MDS receiving potentially curative allogeneic haematopoietic stem cell transplant(allo-HCT) remains to be defined. This is particularly the case for patie...

    V. Potter, L. Gras, L. Koster, N. Kroger, K. Sockel in Bone Marrow Transplantation (2024)

  2. Article

    Der knochenmarktransplantierte Patient auf der Intensivstation

    Die allogene hämatopoetische Stammzelltransplantation (HSZT) stellt für viele Patienten mit maligner, aber auch nichtmaligner hämatologischer Grunderkrankung die einzige Chance auf Heilung dar. Dies gilt insbe...

    S.-S. Stecher, Prof. Dr. H. J. Stemmler in Medizinische Klinik - Intensivmedizin und … (2021)

  3. No Access

    Article

    Post-transplant cyclophosphamide-based haplo-identical transplantation as alternative to matched sibling or unrelated donor transplantation for non-Hodgkin lymphoma: a registry study by the European society for blood and marrow transplantation

    S Dietrich, H Finel, C Martinez, J Tischer, D Blaise, P Chevallier, L Castagna in Leukemia (2016)

  4. No Access

    Article

    Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation

    Adjuvant transfusion of donor lymphocytes (aDLT) may reduce the risk of relapse after allogeneic stem cell transplantation in high-risk AML. We performed a retrospective analysis on the safety and efficacy of ...

    Z Jedlickova, C Schmid, C Koenecke, B Hertenstein in Bone Marrow Transplantation (2016)

  5. No Access

    Article

    Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation

    T Marchand, T Lamy, H Finel, W Arcese, S Choquet, J Finke, A Huynh, G Irrera in Leukemia (2016)

  6. No Access

    Article

    Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas

    Allogeneic hematopoietic cell transplantation (HCT) offers the chance of cure for patients with non-transformed follicular lymphoma (FL), but is associated with the risk of non-relapse mortality (NRM). The aim...

    F Heinzelmann, W Bethge, D W Beelen, M Engelhard, N Kröger in Bone Marrow Transplantation (2016)

  7. No Access

    Article

    Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes

    Limited therapeutic options are available after relapse of acute leukaemia following first reduced intensity conditioning haematopoietic stem cell transplantation (RIC1). A retrospective study on European Soci...

    R Vrhovac, M Labopin, F Ciceri, J Finke, E Holler, J Tischer in Bone Marrow Transplantation (2016)

  8. No Access

    Article

    Sequential therapy combining clofarabine and T-cell-replete HLA-haploidentical haematopoietic SCT is feasible and shows efficacy in the treatment of refractory or relapsed aggressive lymphoma

    Prognosis is poor for patients with biologically aggressive Non-Hodgkin lymphoma (NHL), refractory to chemotherapy or relapsed after autologous transplantation, especially when no disease control before alloge...

    A-K Zoellner, S Fritsch, D Prevalsek, N Engel, M Hubmann in Bone Marrow Transplantation (2015)

  9. No Access

    Article

    A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia

    The use of unmanipulated graft is increasingly adopted in the setting of allogeneic hematopoietic stem cell transplantation from haploidentical family donors (haplo-SCT) in acute leukemia (AL). We analyzed the...

    S Piemontese, F Ciceri, M Labopin, A Bacigalupo, H Huang, S Santarone in Leukemia (2015)

  10. No Access

    Article

    Second haematopoietic SCT using HLA-haploidentical donors in patients with relapse of acute leukaemia after a first allogeneic transplantation

    Haploidentical haematopoietic SCT (HSCT) using T-cell-replete grafts and post-transplant high-dose CY has found increasing acceptance. Our purpose was to evaluate the feasibility and outcome of this strategy a...

    J Tischer, N Engel, S Fritsch, D Prevalsek, M Hubmann in Bone Marrow Transplantation (2014)

  11. Article

    Open Access

    P19. Immunomodulation of blasts in AML-patients (pts) with clinically approved response modifiers to improve anti leukaemic T-cell reactivity: an ex vivo simulation of the clinical situation

    H Schmetzer, Z Stankova, D Deen, A Hirn, Y Vokac in Journal for ImmunoTherapy of Cancer (2014)

  12. No Access

    Article

    Early allo-SCT for AML with a complex aberrant karyotype—results from a prospective pilot study

    In AML, a complex aberrant karyotype is associated with poor response to chemotherapy and dismal prognosis. We prospectively studied the concept of allogeneic haematopoietic SCT (HSCT), performed early and reg...

    C Schmid, M Schleuning, J Tischer, E Holler, K-H Haude in Bone Marrow Transplantation (2012)

  13. No Access

    Article

    Steroidrefraktäre Graft-versus-host-Erkrankung

    Eine 42-jährige Frau entwickelt nach der 2. allogenen Stammzelltransplantation bei akuter myeloischer Leukämie eine lebensbedrohliche steroidrefraktäre Graft-versus-host-Erkrankung der Haut mit Blasenbildung, ...

    Dr. N. Schinwald, A. Rank, J. Tischer, H.J. Kolb in Der Internist (2009)

  14. No Access

    Article

    High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission

    The goal of this analysis was to define the role of the moderate-intensity fludarabin Ara-C amsacrin (FLAMSA)-reduced intensity conditioning (RIC) regimen for patients with high-risk AML undergoing allogeneic ...

    C Schmid, M Schleuning, M Hentrich, G E Markl, A Gerbitz in Bone Marrow Transplantation (2008)

  15. No Access

    Article

    Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML

    We conducted a dose–escalation study with antithymocyte globulin (ATG) in patients undergoing unrelated donor bone marrow transplantation (URD-BMT). This study analyzes the results for 97 patients with chronic...

    M Schleuning, W Günther, J Tischer, G Ledderose, H-J Kolb in Bone Marrow Transplantation (2003)

  16. No Access

    Article

    47jähriger Patient mit rezidivierenden Lungenembolien bei einer angeborenen Störung des Hämostasesystems

    J. Tischer, R. Forstpointner, P. Lohse, E. Hiller in Der Internist (2000)

  17. No Access

    Article

    Pflanzenchemie

    F. Giesecke, W. Rathje, W. Krummel, F. Kertscher in Zeitschrift für analytische Chemie (1942)

  18. No Access

    Article

    Vergleich des von Altbienen erzeugten Wachses mit „Jungfernwachs“ und gewöhnlichem Bienenwachs

    Bienen, die das physiologische Baualter überschritten haben, wurden zu neuerlicher Wachsbildung veranlaßt. Wie aus den ermittelten Kennzahlen hervorgeht, unterscheidet sich dieses Altbienenwachs nicht wesentli...

    R. Jordan, J. Tischer, E. Illner in Zeitschrift für vergleichende Physiologie (1940)

  19. No Access

    Article

    Pflanzenphysiologisch-chemische und agrikulturchemische Mikromethoden

    S. Prát, L. H. Rogers, A. P. Vanselow, B. M. Laurance in Zeitschrift für analytische Chemie (1938)

  20. No Access

    Article

    Bestimmung der Mineralstoffe in Pflanzen

    D. E. Frear, B. Hartwell, J. Smith, S. Damon in Zeitschrift für analytische Chemie (1935)

previous disabled Page of 2